AGRICULTURAL TREATMENT
    3.
    发明申请
    AGRICULTURAL TREATMENT 审中-公开
    农业治理

    公开(公告)号:US20100129474A1

    公开(公告)日:2010-05-27

    申请号:US12441977

    申请日:2007-09-24

    CPC classification number: A01N59/00 A01N37/36 A01N2300/00

    Abstract: A method for the control of microorganisms, fungi or oomycetes in agriculture, said method comprising applying to plants or to the environment thereof, an anti-microbial, anti-fungal or anti-oomycetes effective amount of a combination of: (i) an agriculturally acceptable acidifying agent, and (ii) an agriculturally acceptable source of nitrite ions or a nitrate precursor thereof, wherein the combination of (i) and (ii) acts as a source of nitric oxide. Systems and compositions for use in this method are also described and claimed.

    Abstract translation: 一种用于控制农业中的微生物,真菌或卵菌的方法,所述方法包括向植物或其环境施用抗微生物,抗真菌或抗卵菌的有效量的组合:(i)农业上 可接受的酸化剂,和(ii)农业上可接受的亚硝酸根离子源或其硝酸盐前体,其中(i)和(ii)的组合用作一氧化氮源。 还描述和要求保护用于该方法的系统和组合物。

    Transdermal pharmaceutical delivery composition
    4.
    发明授权
    Transdermal pharmaceutical delivery composition 有权
    透皮药物输送组合物

    公开(公告)号:US08128964B2

    公开(公告)日:2012-03-06

    申请号:US10363439

    申请日:2001-08-30

    CPC classification number: A61K9/06 A61K9/0014 A61K47/02 A61K47/22 Y02A50/491

    Abstract: A pharmaceutically delivery system is described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the pH at the environment. In one embodiment, a barrier consisting of a membrane allows diffusions of the anaesthetic and nitrite ions while preventing direct contact of the skin and acidifying agent.

    Abstract translation: 描述了药物递送系统,其包含药物活性剂和酸化亚硝酸盐作为试剂以在皮肤表面产生局部产生一氧化氮。 剂型可以是任何药学上可接受的载体,并且包含适于降低环境pH值的酸化剂。 在一个实施方案中,由膜组成的屏障允许麻醉剂和亚硝酸根离子的扩散,同时防止皮肤和酸化剂的直接接触。

    PHARMACEUTICAL COMPOSITION CONTAINING NITRATE SOURCE AND AN ACIDIFYING AGENT FOR TREATING SKIN ISCHAEMIA
    5.
    发明申请
    PHARMACEUTICAL COMPOSITION CONTAINING NITRATE SOURCE AND AN ACIDIFYING AGENT FOR TREATING SKIN ISCHAEMIA 审中-公开
    含有硝酸盐的药物组合物和用于治疗皮肤的化学剂ISCHAEMIA

    公开(公告)号:US20080226751A1

    公开(公告)日:2008-09-18

    申请号:US12035855

    申请日:2008-02-22

    CPC classification number: A61K47/12 A61K33/00 A61K45/06 A61K31/19 A61K2300/00

    Abstract: The use of acidified nitrate as an agent to produce local production of nitrate oxide at the skin surface is described in the treatment of peripheral ischaemia and associated conditions. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the pH at the environment. A barrier consisting of a membrane allows diffusions of the nitrate ions while preventing direct contact of the skin and acidifying agent. Amongst the many potential applications for the invention is the management of chronic skin wounds, peripheral ischaemia conditions such as Raynaud's phenomenon. Compositions and methods of use for these applications are described.

    Abstract translation: 在外周缺血和相关病症的治疗中描述了使用酸化的硝酸盐作为药剂在皮肤表面产生局部产生硝酸氧化物的药剂。 剂型可以是任何药学上可接受的载体,并且包含适于降低环境pH值的酸化剂。 由膜构成的屏障允许硝酸根离子的扩散,同时防止皮肤和酸化剂的直接接触。 本发明的许多潜在应用之一是管理慢性皮肤伤口,外周缺血症状如雷诺现象。 描述这些应用的组合物和使用方法。

    Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia
    6.
    发明申请
    Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia 审中-公开
    含有硝酸盐的药物组合物和用于治疗皮肤局部缺血的酸化剂

    公开(公告)号:US20050142218A1

    公开(公告)日:2005-06-30

    申请号:US11065813

    申请日:2005-02-25

    CPC classification number: A61K9/0014 A61K33/00 A61K33/04 A61K47/12

    Abstract: The use of acidified nitrate as an agent to produce local production of nitrate oxide at the skin surface is described in the treatment of peripheral ischaemia and associated conditions. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the pH at the environment. A barrier consisting of a membrane allows diffusions of the nitrate ions while preventing direct contact of the skin and acidifying agent. Amongst the many potential applications for the invention is the management of chronic skin wounds, peripheral ischaemia conditions such as Raynaud's phenomenon. Compositions and methods of use for these applications are described.

    Abstract translation: 在外周缺血和相关病症的治疗中描述了使用酸化的硝酸盐作为药剂在皮肤表面产生局部产生硝酸氧化物的药剂。 剂型可以是任何药学上可接受的载体,并且包含适于降低环境pH值的酸化剂。 由膜构成的屏障允许硝酸根离子的扩散,同时防止皮肤和酸化剂的直接接触。 本发明的许多潜在应用之一是管理慢性皮肤伤口,外周缺血症状如雷诺现象。 描述这些应用的组合物和使用方法。

    Transdermal Pharmaceutical Delivery Composition
    8.
    发明申请
    Transdermal Pharmaceutical Delivery Composition 审中-公开
    透皮药物输送组合物

    公开(公告)号:US20120183595A1

    公开(公告)日:2012-07-19

    申请号:US13360601

    申请日:2012-01-27

    Abstract: A pharmaceutically delivery system is described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the pH at the environment. In one embodiment, a barrier consisting of a membrane allows diffusions of the anaesthetic and nitrite ions while preventing direct contact of the skin and acidifying agent.

    Abstract translation: 描述了药物递送系统,其包含药物活性剂和酸化亚硝酸盐作为试剂以在皮肤表面产生局部产生一氧化氮。 剂型可以是任何药学上可接受的载体,并且包含适于降低环境pH值的酸化剂。 在一个实施方案中,由膜组成的屏障允许麻醉剂和亚硝酸根离子的扩散,同时防止皮肤和酸化剂的直接接触。

    Transdermal pharmaceutical delivery compositions
    9.
    发明授权
    Transdermal pharmaceutical delivery compositions 有权
    透皮药物递送组合物

    公开(公告)号:US08114442B2

    公开(公告)日:2012-02-14

    申请号:US12231555

    申请日:2008-09-03

    CPC classification number: A61K9/06 A61K9/0014 A61K47/02 A61K47/22 Y02A50/491

    Abstract: A pharmaceutically delivery system and method of use therefor are described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the pH at the environment. In one embodiment, a barrier consisting of a membrane allows diffusions of the anaesthetic and nitrite ions while preventing direct contact of the skin and acidifying agent.

    Abstract translation: 本发明描述了一种药物输送系统及其使用方法,其包含药物活性剂和酸化的亚硝酸盐作为在皮肤表面产生局部产生一氧化氮的药剂。 剂型可以是任何药学上可接受的载体,并且包含适于降低环境pH值的酸化剂。 在一个实施方案中,由膜组成的屏障允许麻醉剂和亚硝酸根离子的扩散,同时防止皮肤和酸化剂的直接接触。

Patent Agency Ranking